Connect your AI

Sotera Health SHC Stock-Based Comp

Stock-Based Comp at other companies

Charles River LaboratoriesCRL

$22.38M+70.4%

STERISSTE

$12.9M+31.6%

FortiveFTV

$21.3M-9.0%

BalchemBCPC

$5.36M+40.6%

Natera, Inc.NTRA

$95.11M+22.2%

OkloOKLO

$15.59M+574%

Other financials

Income statement

Revenue$280.0M+10.0%

Gross profit$147.1M+8.6%

Operating income$87.1M-16.2%

Net income$26.6M+301%

EPS (diluted)$0.09+280%

Balance sheet

Cash & equivalents$314.1M+3.2%

Total debt$2.3B-3.2%

Total equity$622.5M+50.3%

Total assets$3.2B+4.5%

Cash flow

Operating cash flow$29.4M-47.0%

CapEx$46.2M+132%

Free cash flow-$16.7M-147%

Valuation

Market cap$4.51B+23.4%

Profitability

Gross margin55.3%+0.1pp

Operating margin27%+0.7pp

Net margin9.9%+7.7pp

FCF margin8.1%—

Returns & leverage

Return on equity22.7%+16.8pp

Debt / equity3.6×-2.0×

Current ratio2.8×+0.4×

Where this comes from

Reported directly by Sotera Health in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Sotera Health’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sotera Health's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Sotera Health's stock-based comp?: Sotera Health (SHC) reported stock-based comp of $14.39M in Q1 2026.
How has Sotera Health's stock-based comp changed year-over-year?: Sotera Health's stock-based comp increased by 98.7% year-over-year, from $7.24M to $14.39M.
What is the long-term trend for Sotera Health's stock-based comp?: Over 4 years (2021 to 2025), Sotera Health's stock-based comp has grown at a 22.1% compound annual growth rate (CAGR), from $13.87M to $30.88M.
What does stock-based comp mean?: Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.